STERIS plc Proceeds from Divestiture of Businesses
STERIS plc (STE) reported Proceeds from Divestiture of Businesses of $0 for the 12-month period ending 2026-03-31, per its 10-K filed 2026-05-29.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromDivestitureOfBusinesses · last filed 2026-05-29
- STERIS plc proceeds from divestiture of businesses for the quarter ending 2020-03-31 was $0.00.
- STERIS plc proceeds from divestiture of businesses for the quarter ending 2019-12-31 was $0.00.
- STERIS plc proceeds from divestiture of businesses for the quarter ending 2019-09-30 was $0.00.
- STERIS plc proceeds from divestiture of businesses for the quarter ending 2019-06-30 was $439.00K.
- STERIS plc proceeds from divestiture of businesses for fiscal 2026 was $0.00, a 100.00% decline from fiscal 2025.
- STERIS plc proceeds from divestiture of businesses for fiscal 2025 was $814.60M, a 8474.74% increase from fiscal 2024.
- STERIS plc proceeds from divestiture of businesses for fiscal 2024 was $9.50M, a 43.42% increase from fiscal 2023.
- STERIS plc proceeds from divestiture of businesses for fiscal 2023 was $6.62M, a 96.10% decline from fiscal 2022.
| Period end | Proceeds from Divestiture of Businesses 3 month | Proceeds from Divestiture of Businesses 6 month | Proceeds from Divestiture of Businesses 9 month | Proceeds from Divestiture of Businesses 12 month | Proceeds from Divestiture of Businesses 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | $0.00 10-K · filed 2026-05-29 | ||||
| 2025-03-31 | $814.60M 10-K · filed 2026-05-29 | $814.56M 10-K · filed 2025-05-29 | |||
| 2024-03-31 | $9.50M 10-K · filed 2026-05-29 | $9.46M 10-K · filed 2024-05-29 | |||
| 2023-03-31 | $6.62M 10-K · filed 2025-05-29 | ||||
| 2022-03-31 | $169.71M 10-K · filed 2024-05-29 | ||||
| 2021-03-31 | $518.00K 10-K · filed 2023-05-26 | ||||
| 2020-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | $0.00 derived: sum of 2 quarters · filed 2022-05-31 | $0.00 derived: sum of 3 quarters · filed 2022-05-31 | $439.00K 10-K · filed 2022-05-31 | |
| 2019-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | $0.00 derived: sum of 2 quarters · filed 2020-02-10 | $439.00K 10-Q · filed 2020-02-10 | ||
| 2019-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07 | $439.00K 10-Q · filed 2019-11-07 | |||
| 2019-06-30 | $439.00K 10-Q · filed 2019-08-07 | ||||
| 2019-03-31 | $2.48M 10-K · filed 2021-05-28 | ||||
| 2018-03-31 | $8.89M 8-K · filed 2021-02-09 | ||||
| 2017-03-31 | $135.71M 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |